최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Microchemical journal, v.169, 2021년, pp.106580 -
Kim, Seong Soon (Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology) , Lee, Ha-Yeon (Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology) , Song, Jin Sook (Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology) , Bae, Myung-Ae (Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology) , Ahn, Sunjoo (Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology)
Abstract Depression, typically understood as a mental disorder, is characterized by monoamine neurotransmitter deficiencies in the central nervous system (CNS). A majority of antidepressants have been developed to increase endogenous levels of monoamine neurotransmitters, such as dopamine (DA), nor...
10.1111/j.1749-6632.1957.tb40753.x B.B. Brodie, P.A. Shore, A concept for a role of serotonin and norepinephrine as chemical mediators in the brain, Annals of the New York Academy of Sciences, 66 (1957) 631-642.
J. Biol. Chem. Roberts 187 1 55 1950 10.1016/S0021-9258(19)50929-2 γ-Aminobutyric acid in brain: its formation from glutamic acid
Neuron Südhof 80 3 675 2013 10.1016/j.neuron.2013.10.022 Neurotransmitter release: the last millisecond in the life of a synaptic vesicle
Science Snyder 224 22 1984 10.1126/science.6322304 Drug and neurotransmitter receptors in the brain
J. Neurochem. Fonnum 42 1 1984 10.1111/j.1471-4159.1984.tb09689.x Glutamate: a neurotransmitter in mammalian brain
Brain Res. Rev. Blokland 21 285 1995 10.1016/0165-0173(95)00016-X Acetylcholine: a neurotransmitter for learning and memory?
Acta Neurobiol. Exp. Arias-Carrión 2007 10.55782/ane-2007-1664 Dopamine, learning, and reward-seeking behavior
W. Danysz, C.G. Parsons, I. Bresink, G. Quack, Glutamate in CNS disorders, Drug News and Perspectives, 8 (1995) 261-261.
Neuropsychiatr. Dis. Treat. Nuss 11 165 2015 Anxiety disorders and GABA neurotransmission: a disturbance of modulation
Biol. Psychiatry Olney 26 5 505 1989 10.1016/0006-3223(89)90072-3 Excitatory amino acids and neuropsychiatrie disorders
Psychopharmacology McEntee 103 2 143 1991 10.1007/BF02244194 Serotonin, memory, and the aging brain
J. Neurochem. Palmer 48 1 8 1987 10.1111/j.1471-4159.1987.tb13120.x Presynaptic serotonergic dysfunction in patients with Alzheimer's disease
The Lancet Turecki 387 1227 2016 10.1016/S0140-6736(15)00234-2 Suicide and suicidal behaviour
Organization 2017 Depression and other common mental disorders: global health estimates
Mol. Psychiatry Hoertel 20 6 718 2015 10.1038/mp.2015.19 Mental disorders and risk of suicide attempt: a national prospective study
CNS Drug Rev. Skolnick 12 123 2006 10.1111/j.1527-3458.2006.00123.x Preclinical and clinical pharmacology of DOV 216,303, a “triple” reuptake inhibitor
Neuropsychiatr. Dis. Treat. Moret 7 9 2011 The importance of norepinephrine in depression
Curr. Neuropharmacol. Marks 6 338 2008 10.2174/157015908787386078 Triple reuptake inhibitors: the next generation of antidepressants
J. Psychiatr. Res. Herrera-Guzmán 43 855 2009 10.1016/j.jpsychires.2008.10.015 Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder
Pharmacol. Ther. Haenisch 129 352 2011 10.1016/j.pharmthera.2010.12.002 Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters
BMC psychiatry Jakobsen 17 58 2017 10.1186/s12888-016-1173-2 Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis
Mol. Psychiatry Hieronymus 21 523 2016 10.1038/mp.2015.53 Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression
Eur. J. Pharmacol. Dhir 568 177 2007 10.1016/j.ejphar.2007.04.028 Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor
J. Pharmacol. Exp. Ther. Cryan 295 1120 2000 Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine2C receptors
Behav. Brain Res. Chenu 172 256 2006 10.1016/j.bbr.2006.05.011 Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test
Nature Kanof 272 329 1978 10.1038/272329a0 Brain histamine receptors as targets for antidepressant drugs
Neuropsychopharmacology Jensen 33 2303 2008 10.1038/sj.npp.1301646 N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT 1A agonist, as a putative mediator of quetiapine's antidepressant activity
Eur. J. Pharmacol. D'Aquila 405 365 2000 10.1016/S0014-2999(00)00566-5 The role of dopamine in the mechanism of action of antidepressant drugs
J. Chromatogr. B Bergh 1028 120 2016 10.1016/j.jchromb.2016.06.011 Validated methods for determination of neurotransmitters and metabolites in rodent brain tissue and extracellular fluid by reversed phase UHPLC-MS/MS
J. Chromatogr. B Zhao 995 15 2015 10.1016/j.jchromb.2015.05.017 Simultaneous determination of amino acid and monoamine neurotransmitters in PC12 cells and rats models of Parkinson’s disease using a sensitizing derivatization reagent by UHPLC-MS/MS
J. Chromatogr. B Patel 818 269 2005 10.1016/j.jchromb.2005.01.008 Simple and rapid determination of serotonin and catecholamines in biological tissue using high-performance liquid chromatography with electrochemical detection
J. Pharm. Biomed. Anal. Han 2019 10.1016/j.jpba.2019.06.043 Development of an underivatized LC-MS/MS method for quantitation of 14 neurotransmitters in rat hippocampus, plasma and urine: Application to CUMS induced depression rats
Psychopharmacology Lin 233 3223 2016 10.1007/s00213-016-4359-x Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice
Neuropsychobiology Pompili 77 23 2019 10.1159/000491604 Tryptophan and kynurenine metabolites: are they related to depression?
J. Neural Transm. Myint 119 245 2012 10.1007/s00702-011-0741-3 The role of the kynurenine metabolism in major depression
Ann. N. Y. Acad. Sci. Paul 1003 250 2003 10.1196/annals.1300.016 Glutamate and depression: clinical and preclinical studies
Am. J. Psychiatry Abdallah 171 1320 2014 10.1176/appi.ajp.2014.14010067 Glutamate metabolism in major depressive disorder
Depression and anxiety Kalueff 24 495 2007 10.1002/da.20262 Role of GABA in anxiety and depression
Am. J. Psychiat. Gelenberg 1980 Tyrosine for the treatment of depression
Israel J. Psychiat. Relat. Sci. Oxenkrug 47 56 2010 Tryptophan-kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later
J. Neurol. Neurosurg. Psychiatry Curzon 33 698 1970 10.1136/jnnp.33.5.698 Tryptophan metabolism in depression
J. Chromatogr. A El-Sherbeni 1627 2020 10.1016/j.chroma.2020.461403 Addressing the instability issue of dopamine during microdialysis: the determination of dopamine, serotonin, methamphetamine and its metabolites in rat brain
J. Chromatogr. B Santos-Fandila 1001 191 2015 10.1016/j.jchromb.2015.07.040 Analysis of 17 neurotransmitters, metabolites and precursors in zebrafish through the life cycle using ultrahigh performance liquid chromatography-tandem mass spectrometry
Br. J. Pharmacol. Nacca 125 1617 1998 10.1038/sj.bjp.0702251 Brain-to-blood partition and in vivo inhibition of 5-hydroxytryptamine reuptake and quipazine-mediated behaviour of nefazodone and its main active metabolites in rodents
Life Sci. Owens 57 24 PL373 1995 10.1016/0024-3205(95)02222-5 The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies
Psychopharmacology Meyer 144 279 1999 10.1007/s002130051004 The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET
Alcohol Olausson 15 77 1998 10.1016/S0741-8329(97)00101-8 Nefazodone attenuates the behavioral and neurochemical effects of ethanol
J. Neurochem. Fryer 72 1117 1999 10.1046/j.1471-4159.1999.0721117.x Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function
Mol. Psychiatry Shytle 7 6 525 2002 10.1038/sj.mp.4001035 Nicotinic acetylcholine receptors as targets for antidepressants
J. Multidiscipl. Healthcare Di Pierro 8 39 2015 10.2147/JMDH.S77766 Role of betaine in improving the antidepressant effect of S-adenosyl-methionine in patients with mild-to-moderate depression
Mol. Psychiatry Luscher 16 4 383 2011 10.1038/mp.2010.120 The GABAergic deficit hypothesis of major depressive disorder
Front. Cell. Neurosci. Fogaça 13 87 2019 10.3389/fncel.2019.00087 Cortical GABAergic dysfunction in stress and depression: new insights for therapeutic interventions
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.